In this study, we investigated the expression of ChAT and related cholinergic markers in four human tumor cell lines: neuroblastoma (SH-SY5Y), lung adenocarcinoma (A549), and two small cell lung cancer lines (H69 and H82) [33]. Here, CHAT is linked to lung adenocarcinoma.